A Bridging Study to Assess the Safety of the Vaccine Adacel in a Clinical Trial.

Trial Profile

A Bridging Study to Assess the Safety of the Vaccine Adacel in a Clinical Trial.

Completed
Phase of Trial: Phase III

Latest Information Update: 27 May 2016

At a glance

  • Drugs DTaP vaccine (Primary)
  • Indications Diphtheria; Pertussis; Tetanus
  • Focus Adverse reactions; Registrational
  • Sponsors Sanofi
  • Most Recent Events

    • 10 Apr 2010 Actual end date (April 2010) added as reported by ClinicalTrials.gov.
    • 10 Apr 2010 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
    • 08 Jan 2010 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top